Tianling Ding
Overview
Explore the profile of Tianling Ding including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang S, Chen H, Dai B, Zheng K, Zheng J, Zhu Y, et al.
Neoplasia
. 2024 Dec;
60:101119.
PMID: 39733690
Primary central nervous system diffused large B-cell lymphoma (PCNS-DLBCL) is a rare type of non-Hodgkin lymphoma restricted to the central nervous system (CNS). To explore its specific pathogenesis and therapeutic...
2.
Xu Q, Li Z, Ding T, Qiu X, Wu Z
Ann Hematol
. 2024 Dec;
104(1):457-465.
PMID: 39690250
This retrospective study investigated the potential drug-drug interactions between trimethoprim-sulfamethoxazole (TMP-SMZ) and high-dose methotrexate (HD-MTX) in adult patients with primary central nervous system lymphoma (PCNSL). A total of 143 Chinese...
3.
4.
Liu J, Tu J, Hu B, Li C, Piao S, Lu Y, et al.
J Magn Reson Imaging
. 2024 Jul;
61(3):1142-1152.
PMID: 38970331
Background: Primary central nervous system lymphoma (PCNSL) carries a poor prognosis. Radiomics may hold potential value in prognostic assessment. Purpose: To develop and validate an MRI-based radiomics model and combine...
5.
Xu M, Xu Y, Yuan L, Shang D, Chen R, Liu S, et al.
Front Immunol
. 2024 May;
15:1390958.
PMID: 38765016
This study presents two cases of type II mixed cryoglobulinemia. One case is essential, while the other is presumably associated with hepatitis B virus (HBV) infection. Both patients tested positive...
6.
Wu Z, Li Z, Qiu X, Zhong M, Ding T
Expert Rev Clin Pharmacol
. 2023 Mar;
16(4):371-381.
PMID: 36946320
Background: High-dose methotrexate (HD-MTX)-based regimens are the standard treatment for patients with primary central nervous system lymphoma (PCNSL); however, MTX has extensive interpatient variability in pharmacokinetics and clinical outcomes, with...
7.
Wang S, Zhu Y, Qian X, Ding T, Yuan Y, Li Y, et al.
Adv Clin Exp Med
. 2023 Mar;
32(8):855-863.
PMID: 36881367
Background: Relapsed/refractory (r/r) central nervous system lymphoma (CNSL) exhibits aggressive behavior and poor outcomes. As an effective bruton tyrosine kinase (BTK) inhibitor, ibrutinib yields benefits in B-cell malignancies. Objectives: We...
8.
Hua J, Ding T, Shao Y
Front Immunol
. 2023 Jan;
13:1040661.
PMID: 36591215
Background: Acute myeloid leukemia (AML) is an aggressive hematopoietic malignancy. Transient receptor potential (TRP) channels in AML still need to be further explored. A TRP channel-related model based on machine...
9.
Sun K, Tao H, Ding T, Li Z, Qiu X, Zhong M, et al.
J Clin Pharm Ther
. 2022 Oct;
47(12):2196-2204.
PMID: 36259502
What Is Known And Objective: Methotrexate (MTX) is an antimetabolic antitumor drug with high individual differences and may lead to severe toxicities in a considerable number of patients. This study...
10.
Ruan H, Wang Z, Chen K, Tang X, Ding T, Zhang C, et al.
Clin Chim Acta
. 2022 Oct;
537:46-50.
PMID: 36243040
Background: Primary central nervous system lymphomas (PCNSL) anaplastic large cell lymphoma (ALCL) are very rare non-Hodgkin's lymphomas, especially in the leptomeninges. Until now, the diagnostics and therapeutics of PCNSL-ALCL is...